Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$149.27
-0.4%
$154.19
$143.13
$175.97
$359.24B0.558.67 million shs6.53 million shs
Kellanova stock logo
K
Kellanova
$60.51
-1.3%
$56.23
$47.63
$71.53
$20.68B0.393.13 million shs4.36 million shs
20 Stocks to Sell Now Cover

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
+0.00%+2.14%-2.11%-4.69%-8.35%
Kellanova stock logo
K
Kellanova
+0.03%+4.82%+5.09%+9.90%-15.41%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
4.9054 of 5 stars
3.23.04.23.93.02.51.9
Kellanova stock logo
K
Kellanova
3.9697 of 5 stars
2.15.02.51.41.92.51.3

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
2.46
Hold$175.8617.81% Upside
Kellanova stock logo
K
Kellanova
2.15
Hold$61.151.06% Upside

Current Analyst Ratings

Latest K and JNJ Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/3/2024
Kellanova stock logo
K
Kellanova
JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetNeutral ➝ Neutral$59.00 ➝ $66.00
5/3/2024
Kellanova stock logo
K
Kellanova
TD Cowen
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetHold ➝ Hold$57.00 ➝ $62.00
4/18/2024
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
HSBC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeHold ➝ Buy$169.00 ➝ $170.00
4/17/2024
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetEqual Weight ➝ Equal Weight$168.00 ➝ $167.00
4/17/2024
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$180.00 ➝ $170.00
4/17/2024
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOutperform ➝ Outperform$181.00 ➝ $175.00
4/15/2024
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$215.00
3/13/2024
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$215.00
3/1/2024
Kellanova stock logo
K
Kellanova
DA Davidson
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy$67.00
2/28/2024
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform ➝ Outperform$181.00
2/20/2024
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$215.00
(Data available from 5/5/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$85.16B4.22$13.67 per share10.92$29.09 per share5.13
Kellanova stock logo
K
Kellanova
$13.12B1.58$4.50 per share13.46$9.59 per share6.31

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$35.15B$16.049.3113.662.4645.26%36.70%15.07%7/18/2024 (Estimated)
Kellanova stock logo
K
Kellanova
$951M$2.6722.6615.922.326.41%37.07%8.29%8/1/2024 (Estimated)

Latest K and JNJ Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/2/2024Q1 2024
Kellanova stock logo
K
Kellanova
$0.85$1.01+$0.16$1.24$3.16 billion$3.20 billion    
4/16/2024Q1 24
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$2.64$2.71+$0.07$3.22$21.39 billion$21.38 billion    
2/8/2024Q4 2023
Kellanova stock logo
K
Kellanova
$0.74$0.78+$0.04$1.48$3.07 billion$3.17 billion    

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$4.763.19%+5.70%29.68%63 Years
Kellanova stock logo
K
Kellanova
$2.243.70%+0.87%83.90%N/A

Latest K and JNJ Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
4/26/2024
Kellanova stock logo
K
Kellanova
Quarterly$0.563.85%6/3/20246/3/20246/14/2024
4/16/2024
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
quarterly$1.243.36%5/20/20245/21/20246/4/2024
2/16/2024
Kellanova stock logo
K
Kellanova
quarterly$0.564.02%2/29/20243/1/20243/15/2024
(Data available from 1/1/2013 forward)

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
0.36
1.17
0.91
Kellanova stock logo
K
Kellanova
1.34
0.62
0.41

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
69.55%
Kellanova stock logo
K
Kellanova
83.87%

Insider Ownership

CompanyInsider Ownership
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
0.16%
Kellanova stock logo
K
Kellanova
1.80%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
131,9002.41 billion2.40 billionOptionable
Kellanova stock logo
K
Kellanova
23,000341.76 million335.61 millionOptionable

K and JNJ Headlines

SourceHeadline
Analysts Conflicted on These Consumer Goods Names: Kellanova (K) and Church & Dwight (CHD)Analysts Conflicted on These Consumer Goods Names: Kellanova (K) and Church & Dwight (CHD)
markets.businessinsider.com - May 4 at 6:03 AM
Kellanova Beats Expectations with Strong Q1 Sales Amid Higher PricesKellanova Beats Expectations with Strong Q1 Sales Amid Higher Prices
econotimes.com - May 4 at 1:03 AM
Kellanova (NYSE:K) Announces Quarterly  Earnings ResultsKellanova (NYSE:K) Announces Quarterly Earnings Results
marketbeat.com - May 4 at 12:31 AM
JPMorgan Chase & Co. Boosts Kellanova (NYSE:K) Price Target to $66.00JPMorgan Chase & Co. Boosts Kellanova (NYSE:K) Price Target to $66.00
marketbeat.com - May 3 at 9:42 PM
Analysts Offer Insights on Consumer Goods Companies: Church & Dwight (CHD) and Kellanova (K)Analysts Offer Insights on Consumer Goods Companies: Church & Dwight (CHD) and Kellanova (K)
markets.businessinsider.com - May 3 at 8:02 PM
Kellogg Company (NYSE:K) Q1 2024 Earnings Call TranscriptKellogg Company (NYSE:K) Q1 2024 Earnings Call Transcript
finance.yahoo.com - May 3 at 8:02 PM
Kellanova (NYSE:K) Releases FY 2024 Earnings GuidanceKellanova (NYSE:K) Releases FY 2024 Earnings Guidance
marketbeat.com - May 3 at 4:52 PM
Kellanova targets wholesalers in UK depot roadshowKellanova targets wholesalers in UK depot roadshow
thegrocer.co.uk - May 3 at 10:59 AM
Kellanova’s return to ‘full commercial activity,’ debut of Netflix’s Unfrosted movie promise strong results for full yearKellanova’s return to ‘full commercial activity,’ debut of Netflix’s Unfrosted movie promise strong results for full year
foodnavigator-usa.com - May 3 at 10:59 AM
Kellanova First Quarter 2024 Earnings: Revenues Beat Expectations, EPS LagsKellanova First Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
finance.yahoo.com - May 3 at 10:59 AM
Kellanova Co (K) (Q1 2024) Earnings Call Transcript Highlights: Strong Start with Robust Sales ...Kellanova Co (K) (Q1 2024) Earnings Call Transcript Highlights: Strong Start with Robust Sales ...
finance.yahoo.com - May 3 at 5:58 AM
Q1 2024 Kellanova Earnings Call (Tentative)Q1 2024 Kellanova Earnings Call (Tentative)
finance.yahoo.com - May 3 at 5:58 AM
Kellanova: Hold Rating Justified by Mixed Financial Signals and Market PressuresKellanova: Hold Rating Justified by Mixed Financial Signals and Market Pressures
markets.businessinsider.com - May 2 at 6:49 PM
Why Kellenova Stock Jumped Despite The Food Company Missing Earnings EstimatesWhy Kellenova Stock Jumped Despite The Food Company Missing Earnings Estimates
msn.com - May 2 at 6:49 PM
Pop-Tarts maker Kellanova tops estimates on steady demand, higher pricesPop-Tarts maker Kellanova tops estimates on steady demand, higher prices
msn.com - May 2 at 6:49 PM
Why Are Kellanova (K) Shares Soaring TodayWhy Are Kellanova (K) Shares Soaring Today
finance.yahoo.com - May 2 at 6:49 PM
Kellanova (NYSE:K) Trading Up 8.2%Kellanova (NYSE:K) Trading Up 8.2%
marketbeat.com - May 2 at 2:26 PM
Kellanova Posts Upbeat Q1 Results Amid Steady DemandKellanova Posts Upbeat Q1 Results Amid Steady Demand
esmmagazine.com - May 2 at 1:48 PM
Food Giant Kellanova Shines Despite Challenges, Sticks To Annual GuidanceFood Giant Kellanova Shines Despite Challenges, Sticks To Annual Guidance
msn.com - May 2 at 1:48 PM
Kellanova Co (K) Q1 Earnings: Aligns with Analyst Projections Amidst Market ChallengesKellanova Co (K) Q1 Earnings: Aligns with Analyst Projections Amidst Market Challenges
finance.yahoo.com - May 2 at 1:48 PM
Kellanova nears session high amid report TOMS Capital takes significant stakeKellanova nears session high amid report TOMS Capital takes significant stake
msn.com - May 2 at 1:48 PM
Kellanova earnings beat estimates and CEO strikes bullish toneKellanova earnings beat estimates and CEO strikes bullish tone
msn.com - May 2 at 1:48 PM
Dismantling misconceptions about shrinkflation: Kellanova CEODismantling misconceptions about shrinkflation: Kellanova CEO
finance.yahoo.com - May 2 at 1:48 PM
K Stock Earnings: Kellogg Beats EPS, Beats Revenue for Q1 2024K Stock Earnings: Kellogg Beats EPS, Beats Revenue for Q1 2024
investorplace.com - May 2 at 1:03 PM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

All Headlines

Company Descriptions

Johnson & Johnson logo

Johnson & Johnson

NYSE:JNJ
Johnson & Johnson, together with its subsidiaries, researches, develops, manufactures, and sells various products in the healthcare field worldwide. The company's Innovative Medicine segment offers products for various therapeutic areas, such as immunology, including rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis; infectious diseases comprising HIV/AIDS; neuroscience, consisting of mood disorders, neurodegenerative disorders, and schizophrenia; oncology, such as prostate cancer, hematologic malignancies, lung cancer, and bladder cancer; cardiovascular and metabolism, including thrombosis, diabetes, and macular degeneration; and pulmonary hypertension comprising pulmonary arterial hypertension through retailers, wholesalers, distributors, hospitals, and healthcare professionals for prescription use. Its MedTech segment provides Interventional Solutions, including electrophysiology products to treat heart rhythm disorders; the heart recovery portfolio, which includes technologies to treat severe coronary artery disease requiring high-risk PCI or AMI cardiogenic shock; and neurovascular care that treats hemorrhagic and ischemic stroke. this segment also offers an orthopaedics portfolio that includes products and enabling technologies that support hips, knees, trauma, spine, sports, and other; surgery portfolios comprising advanced and general surgery technologies, as well as solutions for breast aesthetics, ear, nose, and throat procedures; contact lenses under the ACUVUE Brand; and TECNIS intraocular lenses for cataract surgery. It distributes its products to wholesalers, hospitals, and retailers, as well as physicians, nurses, hospitals, eye care professionals, and clinics. Johnson & Johnson was founded in 1886 and is based in New Brunswick, New Jersey.
Kellanova logo

Kellanova

NYSE:K
Kellanova, together with its subsidiaries, manufactures and markets snacks and convenience foods in North America, Europe, Latin America, the Asia Pacific, the Middle East, Australia, and Africa. Its principal products include crackers, crisps, savory snacks, toaster pastries, cereal bars, granola bars and bites, ready-to-eat cereals, frozen waffles, veggie foods, and noodles. The company offers its products under the Kellogg's, Cheez-It, Pringles, Austin, Parati, RXBAR, Eggo, Morningstar Farms, Bisco, Club, Luxe, Minueto, Special K, Toasteds, Town House, Zesta, Zoo Cartoon, Choco Krispis, Crunchy Nut, Kashi, Nutri-Grain, Squares, Zucaritas, Rice Krispies Treats, Sucrilhos, Pop-Tarts, K-Time, Sunibrite, Split Stix, LCMs, Coco Pops, Krave, Frosties, Rice Krispies Squares, Incogmeato, Veggitizers, Gardenburger, Trink, Carr's, Kellogg's Extra, Müsli, Fruit n Fibre, Kellogg's Crunchy Nut, Country Store, Smacks, Honey Bsss, Zimmy's, Toppas, Tresor, Froot Ring, Chocos, Chex, Guardian, Just Right, Sultana Bran, Rice Bubbles, Sustain, and Choco Krispies brand names. It sells its products to retailers through direct sales forces, as well as brokers and distributors. The company was formerly known as Kellogg Company and changed its name to Kellanova in October 2023. Kellanova was founded in 1906 and is headquartered in Chicago, Illinois.